BioNTech is a publicly traded company trading on NASDAQ, led by CEO Ugur Sahin.
Upcoming earnings announcement for BioNTech
Past 12 earnings reports for BioNTech
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.38Est: -$0.47 | +19.1% | $1.1BEst: $889.5M | +18.7% | — |
| Nov 3, 2025 | Q3 2025 | -$0.14Est: $0.75 | -118.7% | $1.8BEst: $1.2B | +49.2% | — |
| Aug 4, 2025 | Q2 2025 | -$1.82Est: -$1.31 | -38.9% | $295.7MEst: $643.9M | -54.1% | — |
| May 5, 2025 | Q1 2025 | -$1.82Est: -$2.35 | +22.6% | $192.2MEst: $161.7M | +18.9% | — |
| Mar 10, 2025 | Q4 2024 | $1.15Est: $0.37 | +210.8% | $1.3BEst: $1.2B | +10.4% | — |
| Nov 4, 2024 | Q3 2024 | $0.89Est: -$1.67 | +153.3% | $1.4BEst: $639.1M | +114.0% | — |
| Aug 5, 2024 | Q2 2024 | -$3.62Est: -$2.20 | -64.5% | $138.6MEst: $170.4M | -18.7% | — |
| May 6, 2024 | Q1 2024 | -$1.42Est: -$1.17 | -21.4% | $203.7MEst: $460.5M | -55.8% | — |
| Mar 20, 2024 | Q4 2023 | $2.05Est: $2.64 | -22.5% | $1.6BEst: $2.0B | -20.0% | — |
| Nov 6, 2023 | Q3 2023 | $0.73Est: $0.62 | +17.7% | $974.5MEst: $1.1B | -8.1% | — |
| Aug 7, 2023 | Q2 2023 | -$0.86Est: -$0.75 | -14.7% | $182.8MEst: $786.2M | -76.8% | — |
| May 8, 2023 | Q1 2023 | $2.20Est: $0.16 | +1275.0% | $1.4BEst: $1.6B | -14.3% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.